A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients

Clinical trial NCT01391013 · COMPLETED

Trial details

NCT number: NCT01391013
Sponsor: Janssen-Cilag S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus 1

Start date: 2009-06-01
Primary completion: 2011-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.